From: OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
OLA1 Low (N = 63) | OLA1 High (N = 48) | p | |
---|---|---|---|
Age | 58.84 ± 14.21 | 49.56 ± 15.12 | 0.797 |
Gender | 0.497 | ||
Male | 34(54.0%) | 29(60.4%) | |
Female | 29(46.0%) | 19(39.6%) | |
Tumor location | 0.577 | ||
Right colon | 20(31.7%) | 11(22.9%) | |
Left colon | 13(20.6%) | 12(25.0%) | |
Rectum | 30(47.6%) | 24(52.1%) | |
T stage | 0.147 | ||
T1 | 4(6.3%) | 3(6.2%) | |
T2 | 16(25.4%) | 7(14.6%) | |
T3 | 22(34.9%) | 27(56.2%) | |
T4 | 21(33.3%) | 11(22.9%) | |
N stage | 0.702 | ||
N0 | 36(57.1%) | 22(45.8%) | |
N1 | 14(22.2%) | 13(27.1%) | |
N2a | 4(6.3%) | 4(8.3%) | |
N2b | 9(14.3%) | 9(18.8%) | |
M stage | 0.159 | ||
M0 | 57(90.5%) | 39(81.2%) | |
M1 | 6(9.5%) | 9(18.8%) | |
Tumor size | 0.938 | ||
≤ 3 cm | 17(27.0%) | 14(29.2%) | |
3-5 cm | 31(49.2%) | 22(45.8%) | |
>5 cm | 15(23.8%) | 12(25.0%) | |
Tumor differentiation | 0.425 | ||
Poor | 4(6.3%) | 2(4.2%) | |
Moderate | 25(39.7%) | 25(52.1%) | |
Well | 24(38.1%) | 15(31.2%) | |
Mucous | 7(11.1%) | 6(12.5%) | |
Signet ring | 3(4.8%) | 0(0.0%) | |
Chemotherapy | 0.721 | ||
No | 44(69.8%) | 32(66.7%) | |
Yes | 19(30.2%) | 16(33.3%) |